{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,22]],"date-time":"2025-11-22T11:42:06Z","timestamp":1763811726446,"version":"3.41.2"},"reference-count":97,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T00:00:00Z","timestamp":1741824000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Calcific aortic valve stenosis (CAVS) is a common cardiovascular condition associated with significant adverse events and high mortality rates. Unfortunately, there are currently no effective pharmacological treatments to halt or prevent its progression. Through our analysis of global trends and treatment strategies, we have identified valuable insights and promising therapeutic possibilities. Additionally, by utilizing bibliometric and visualization techniques, we provide a comprehensive overview of the current research landscape in this field.<\/jats:p><\/jats:sec><jats:sec><jats:title>Method<\/jats:title><jats:p>According to our design idea, we used the Web of Science database to select publications on aortic stenosis and related treatments. Through our VOSviewer and CiteSpace analysis, a total of 787 articles have been analyzed by September 2024. We also summarize and explore the most prolific authors, the most prolific countries, and the journals and institutions that publish the most articles.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A visual analysis of the collected articles reveals that Canada and the United States have the highest publication volumes in this field. Among institutions, Harvard University in the U.S. leads in publication count, followed by Laval University in Canada and the University of California in the U.S. The top three research hotspots are stenosis, calcification, and progression. The journal with the highest number of publications in this area is Frontiers in Cardiovascular Medicine, followed by Catheterization and Cardiovascular Interventions and Arteriosclerosis, Thrombosis and Vascular Biology. Furthermore, research on CAVS treatment spans various directions and focuses, including therapeutic approaches, pathogenesis, and diagnostic methods.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Research into CAVS treatment has advanced significantly over the years. While interventional and surgical valve replacement remains the mainstay treatments for aortic stenosis, they are insufficient to fully meet the needs of the patient. Emerging priorities now focus on improving diagnostics, exploring innovative therapies, uncovering disease mechanisms, and developing novel drugs. These findings highlight the evolving demands in this field and underscore the need for continued research to address these challenges.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fphar.2025.1431311","type":"journal-article","created":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T07:05:59Z","timestamp":1741849559000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Bibliometric analysis of treatment modalities in calcific aortic valve stenosis"],"prefix":"10.3389","volume":"16","author":[{"given":"Yang","family":"He","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue-Jiao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhao-Jun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liang","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,3,13]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1007\/s11192-011-0406-x","article-title":"The field-standardized average impact of national research systems compared to world average: the case of Italy","volume":"88","author":"Abramo","year":"2011","journal-title":"Scientometrics"},{"key":"B2","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.ejca.2018.04.017","article-title":"Mapping the European cancer research landscape: an evidence base for national and Pan-European research and funding","volume":"100","author":"Begum","year":"2018","journal-title":"Eur. J. Cancer."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.2174\/0929867325666180716104159","article-title":"The role of matrix gla protein (MGP) in vascular calcification","volume":"27","author":"Bj\u00f8rklund","year":"2020","journal-title":"Curr. Med. Chem."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1016\/S0140-6736(16)00586-9","article-title":"Management strategies and future challenges for aortic valve disease","volume":"387","author":"Bonow","year":"2016","journal-title":"Lancet"},{"key":"B5","doi-asserted-by":"publisher","first-page":"11105","DOI":"10.3390\/ijms241311105","article-title":"The complex relationship between hypoxia signaling, mitochondrial dysfunction and inflammation in calcific aortic valve disease: insights from the molecular mechanisms to therapeutic approaches","volume":"24","author":"Bouhamida","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1161\/CIRCULATIONAHA.106.178458","article-title":"Assessment of coronary artery disease by cardiac computed tomography: a scientific statement from the American heart association committee on cardiovascular imaging and intervention, council on cardiovascular Radiology and intervention, and committee on cardiac imaging, council on clinical cardiology","volume":"114","author":"Budoff","year":"2006","journal-title":"Circulation"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1098\/rstb.2007.2127","article-title":"Valvular endothelial cells and the mechanoregulation of valvular pathology","volume":"362","author":"Butcher","year":"2007","journal-title":"Philos. Trans. R. Soc. B-Biol. Sci."},{"key":"B96","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.jacc.2012.03.052","article-title":"Impact of Metabolic Syndrome on Progression of Aortic Stenosis Influence of Age and Statin Therapy","volume":"60","author":"Capoulade","year":"2012","journal-title":"J. Am. Coll. Cardiol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/s41467-024-44726-0","article-title":"Enhancing aortic valve drug delivery with PAR2-targeting magnetic nano-cargoes for calcification alleviation","volume":"15","author":"Chen","year":"2024","journal-title":"Nat. Commun."},{"key":"B9","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.atherosclerosis.2018.08.029","article-title":"Inflammatory and metabolic mechanisms underlying the calcific aortic valve disease","volume":"277","author":"Cho","year":"2018","journal-title":"Atherosclerosis"},{"key":"B10","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1161\/01.cir.104.3.249","article-title":"Effects of lipid-lowering by simvastatin on human atherosclerotic lesions: a longitudinal study by high-resolution, noninvasive magnetic resonance imaging","volume":"104","author":"Corti","year":"2001","journal-title":"Circulation"},{"key":"B11","doi-asserted-by":"publisher","first-page":"2389","DOI":"10.1056\/NEJMoa043876","article-title":"A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis","volume":"352","author":"Cowell","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"B12","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1007\/s11883-020-0821-7","article-title":"Calcific aortic valve stenosis and atherosclerotic calcification","volume":"22","author":"de Oliveira","year":"2020","journal-title":"Curr. Atheroscler. Rep."},{"key":"B13","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1161\/CIRCRESAHA.121.319914","article-title":"Sex differences and similarities in valvular heart disease","volume":"130","author":"Desjardin","year":"2022","journal-title":"Circ. Res."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1016\/j.echo.2018.05.012","article-title":"A new three-dimensional echocardiography method to quantify aortic valve calcification","volume":"31","author":"D'Humi\u00e8res","year":"2018","journal-title":"J. Am. Soc. Echocardiogr."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1161\/CIRCULATIONAHA.121.057008","article-title":"Vitamin K2 and D in patients with aortic valve calcification: a randomized double-blinded clinical trial","volume":"145","author":"Diederichsen","year":"2022","journal-title":"Circulation"},{"key":"B16","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1007\/s10660-020-09410-7","article-title":"Knowledge mapping of platform research: a visual analysis using VOSviewer and CiteSpace","volume":"22","author":"Ding","year":"2022","journal-title":"Electron. Commer. Res."},{"key":"B17","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1001\/jamacardio.2022.0987","article-title":"Lipoprotein(a) and its significance in cardiovascular disease: a review","volume":"7","author":"Duarte","year":"2022","journal-title":"JAMA Cardiol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1093\/ehjci\/jead153","article-title":"Multi-modality imaging in aortic stenosis: an EACVI clinical consensus document","volume":"24","author":"Dweck","year":"2023","journal-title":"Eur. Heart J. Cardiovasc. Imaging."},{"key":"B19","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1007\/s00330-005-2919-2","article-title":"First performance evaluation of a dual-source CT (DSCT) system","volume":"16","author":"Flohr","year":"2006","journal-title":"Eur. Radiol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1194\/jlr.R052258","article-title":"Antisense inhibition of apolipoprotein (a) to lower plasma lipoprotein (a) levels in humans","volume":"57","author":"Graham","year":"2016","journal-title":"J. Lipid. Res."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-019-0272-9","article-title":"Inhibition of acetylation of histones 3 and 4 attenuates aortic valve calcification","volume":"51","author":"Gu","year":"2019","journal-title":"Exp. Mol. Med."},{"key":"B22","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.pcad.2020.06.002","article-title":"Lipoprotein(a) and calcific aortic valve stenosis: a systematic review","volume":"63","author":"Guddeti","year":"2020","journal-title":"Prog. Cardiovasc. Dis."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1016\/j.jcmg.2010.08.016","article-title":"Image quality and radiation exposure with a low tube voltage protocol for coronary CT angiography results of the PROTECTION II Trial","volume":"3","author":"Hausleiter","year":"2010","journal-title":"JACC Cardiovasc. Imaging."},{"key":"B24","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1161\/CIRCRESAHA.123.321760","article-title":"Cardiovascular calcification heterogeneity in chronic kidney disease","volume":"132","author":"Hutcheson","year":"2023","journal-title":"Circ. Res."},{"key":"B25","doi-asserted-by":"publisher","first-page":"e007213","DOI":"10.1161\/CIRCINTERVENTIONS.118.007213","article-title":"Prognostic value of hs-CRP after transcatheter aortic valve implantation","volume":"11","author":"Iglesias-\u00e1lvarez","year":"2018","journal-title":"Circ. Cardiovasc. Interv."},{"key":"B26","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1093\/eurheartj\/ehac818","article-title":"Sortilin enhances fibrosis and calcification in aortic valve disease by inducing interstitial cell heterogeneity","volume":"44","author":"Iqbal","year":"2023","journal-title":"Eur. Heart J."},{"key":"B27","doi-asserted-by":"publisher","first-page":"5292","DOI":"10.1111\/jcmm.14405","article-title":"MicroRNA-638 inhibits human aortic valve interstitial cell calcification by targeting Sp7","volume":"23","author":"Jiao","year":"2019","journal-title":"J. Cell. Mol. Med."},{"key":"B28","doi-asserted-by":"publisher","first-page":"989539","DOI":"10.3389\/fcvm.2022.989539","article-title":"IL6 gene polymorphism association with calcific aortic valve stenosis and influence on serum levels of interleukin-6","volume":"9","author":"Junco-Vicente","year":"2022","journal-title":"Front. Cardiovasc. Med."},{"key":"B29","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/j.jacc.2013.09.038","article-title":"Elevated lipoprotein(a) and risk of aortic valve stenosis in the general population","volume":"63","author":"Kamstrup","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"101543","DOI":"10.1016\/j.ijcha.2024.101543","article-title":"Role of Lipoprotein (A) in aortic valve stenosis: novel disease mechanisms and emerging pharmacotherapeutic approaches","volume":"55","author":"Khan","year":"2024","journal-title":"IJC Heart Vasc."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1056\/NEJMoa1200384","article-title":"Two-year outcomes after transcatheter or surgical aortic-valve replacement","volume":"366","author":"Kodali","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"B32","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1111\/hir.12295","article-title":"Application of bibliometrics in medicine: a historical bibliometrics analysis","volume":"38","author":"Kokol","year":"2021","journal-title":"Heatlth Info. Libr. J."},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241713622","article-title":"Novel pharmacological therapies for the management of hyperlipoproteinemia(a)","volume":"24","author":"Kosmas","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"B34","doi-asserted-by":"publisher","first-page":"7434","DOI":"10.3390\/ijms21207434","article-title":"Ultrastructural pathology of atherosclerosis, calcific aortic valve disease, and bioprosthetic heart valve degeneration: commonalities and differences","volume":"21","author":"Kostyunin","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"B35","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1093\/eurheartj\/ehab757","article-title":"Calcific aortic valve disease: from molecular and cellular mechanisms to medical therapy","volume":"43","author":"Kraler","year":"2022","journal-title":"Eur. Heart J."},{"key":"B94","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1111\/j.1365-2796.2012.02592.x","article-title":"Lipoprotein(a): resurrected by genetics","volume":"273","author":"Kronenberg","year":"2013","journal-title":"J. Intern. Med."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1016\/j.jtcvs.2017.01.052","article-title":"The shift of macrophages toward M1 phenotype promotes aortic valvular calcification","volume":"153","author":"Li","year":"2017","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"B37","doi-asserted-by":"publisher","first-page":"16006","DOI":"10.1038\/nrdp.2016.6","article-title":"Calcific aortic stenosis","volume":"2","author":"Lindman","year":"2016","journal-title":"Nat. Rev. Dis. Prim."},{"key":"B38","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1161\/CIRCULATIONAHA.109.192703","article-title":"Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association's strategic Impact Goal through 2020 and beyond","volume":"121","author":"Lloyd-Jones","year":"2010","journal-title":"Circulation"},{"key":"B39","doi-asserted-by":"publisher","first-page":"983","DOI":"10.2459\/JCM.0b013e32802e6c3d","article-title":"Aortic valve stenosis and coronary artery disease: pathophysiological and clinical links","volume":"8","author":"Mazzone","year":"2007","journal-title":"J. Cardiovasc. Med."},{"key":"B40","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.omega.2016.12.004","article-title":"A bibliometric analysis of operations research and management science","volume":"73","author":"Merig\u00f3","year":"2017","journal-title":"Omega-Int. J. Manage. Sci."},{"key":"B41","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1161\/ATVBAHA.107.154989","article-title":"Association between plasma LDL particle size, valvular accumulation of oxidized LDL, and inflammation in patients with aortic stenosis","volume":"28","author":"Mohty","year":"2008","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"3389","DOI":"10.3390\/cells11213389","article-title":"Cellular senescence, aging and non-aging processes in calcified aortic valve stenosis: from bench-side to bedside","volume":"11","author":"Moln\u00e1r","year":"2022","journal-title":"Cells"},{"key":"B43","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1038\/s41569-023-00845-7","article-title":"Calcific aortic valve disease: mechanisms, prevention and treatment","volume":"20","author":"Moncla","year":"2023","journal-title":"Nat. Rev. Cardiol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"2548","DOI":"10.1093\/cvr\/cvab267","article-title":"Impairment of mitophagy and autophagy accompanies calcific aortic valve stenosis favouring cell death and the severity of disease","volume":"118","author":"Morciano","year":"2022","journal-title":"Cardiovasc. Res."},{"key":"B45","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.phrs.2018.08.020","article-title":"Novel pharmacological targets for calcific aortic valve disease: prevention and treatments","volume":"136","author":"Myasoedova","year":"2018","journal-title":"Pharmacol. Res."},{"key":"B46","doi-asserted-by":"publisher","first-page":"e13527","DOI":"10.1111\/eci.13527","article-title":"Aortic valvular stenosis: novel therapeutic strategies","volume":"51","author":"Natorska","year":"2021","journal-title":"Eur. J. Clin. Invest."},{"key":"B47","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1016\/j.yjmcc.2009.08.008","article-title":"Notch1 represses osteogenic pathways in aortic valve cells","volume":"47","author":"Nigam","year":"2009","journal-title":"J. Mol. Cell. Cardiol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1001\/jama.2022.5050","article-title":"Single ascending dose study of a short interfering RNA targeting lipoprotein(a) production in individuals with elevated plasma lipoprotein(a) levels","volume":"327","author":"Nissen","year":"2022","journal-title":"JAMA"},{"key":"B49","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.1056\/NEJMoa2211023","article-title":"Small interfering RNA to reduce lipoprotein(a) in cardiovascular disease","volume":"387","author":"O'Donoghue","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"B50","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1016\/j.jacc.2024.05.058","article-title":"The off-treatment effects of olpasiran on lipoprotein(a) lowering: OCEAN(a)-DOSE extension period results","volume":"84","author":"O'Donoghue","year":"2024","journal-title":"J. Am. Coll. Cardiol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1016\/j.jcmg.2020.12.034","article-title":"Computed tomography-derived 3D modeling to guide sizing and planning of transcatheter mitral valve interventions","volume":"14","author":"Ooms","year":"2021","journal-title":"JACC Cardiovasc. Imaging."},{"key":"B52","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1056\/NEJMe0807001","article-title":"Calcific aortic stenosis--time to look more closely at the valve","volume":"359","author":"Otto","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"B53","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1161\/01.cir.90.2.844","article-title":"Characterization of the early lesion of 'degenerative' valvular aortic stenosis. Histological and immunohistochemical studies","volume":"90","author":"Otto","year":"1994","journal-title":"Circulation"},{"key":"B54","doi-asserted-by":"publisher","first-page":"e72","DOI":"10.1161\/CIR.0000000000000923","article-title":"2020 ACC\/AHA guideline for the management of patients with valvular heart disease: a report of the American College of cardiology\/American heart association joint committee on clinical practice guidelines","volume":"143","author":"Otto","year":"2021","journal-title":"Circulation"},{"key":"B55","doi-asserted-by":"publisher","first-page":"e200","DOI":"10.1002\/mco2.200","article-title":"Vascular calcification: molecular mechanisms and therapeutic interventions","volume":"4","author":"Pan","year":"2023","journal-title":"MedComm"},{"key":"B56","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.atherosclerosis.2020.02.016","article-title":"Innate and adaptive immunity in cardiovascular calcification","volume":"306","author":"Passos","year":"2020","journal-title":"Atherosclerosis"},{"key":"B57","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1016\/j.jcmg.2019.01.045","article-title":"Why and how to measure aortic valve calcification in patients with aortic stenosis","volume":"12","author":"Pawade","year":"2019","journal-title":"JACC Cardiovasc. Imaging"},{"key":"B58","doi-asserted-by":"publisher","first-page":"2418","DOI":"10.1161\/CIRCULATIONAHA.121.053708","article-title":"Effect of denosumab or alendronic acid on the progression of aortic stenosis: a double-blind randomized controlled trial","volume":"143","author":"Pawade","year":"2021","journal-title":"Circulation"},{"key":"B97","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.jacbts.2020.05.004","article-title":"Genetic and In Vitro Inhibition of PCSK9 and Calcific Aortic Valve Stenosis","volume":"5","author":"Perrot","year":"2020","journal-title":"JACC-Basic Transl. Sci"},{"key":"B59","doi-asserted-by":"publisher","first-page":"611922","DOI":"10.3389\/fcell.2021.611922","article-title":"Mitochondrial dysfunction: cause or consequence of vascular calcification?","volume":"9","author":"Phadwal","year":"2021","journal-title":"Front. Cell. Dev. Biol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/s41591-018-0272-7","article-title":"Privacy in the age of medical big data","volume":"25","author":"Price","year":"2019","journal-title":"Nat. Med."},{"key":"B61","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/s41586-018-0198-8","article-title":"Oxidized phospholipids are proinflammatory and proatherogenic in hypercholesterolaemic mice","volume":"558","author":"Que","year":"2018","journal-title":"Nature"},{"key":"B62","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1161\/CIRCULATIONAHA.119.044195","article-title":"Slowing progression of cardiovascular calcification with SNF472 in patients on hemodialysis: results of a randomized phase 2b study","volume":"141","author":"Raggi","year":"2020","journal-title":"Circulation"},{"key":"B63","doi-asserted-by":"publisher","first-page":"2696","DOI":"10.1016\/j.jacc.2015.10.011","article-title":"Calcific aortic valve disease in familial hypercholesterolemia: the LDL-density-gene effect","volume":"66","author":"Rajamannan","year":"2015","journal-title":"J. Am. Coll. Cardiol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1038\/ncpcardio0827","article-title":"Calcific aortic stenosis: an update","volume":"4","author":"Rajamannan","year":"2007","journal-title":"Nat. Clin. Pract. Cardiovasc Med."},{"key":"B65","doi-asserted-by":"publisher","first-page":"100029","DOI":"10.1016\/j.xgen.2021.100029","article-title":"GA4GH: international policies and standards for data sharing across genomic research and healthcare","volume":"1","author":"Rehm","year":"2021","journal-title":"Cell Genom"},{"key":"B66","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1056\/NEJMoa0804602","article-title":"Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis","volume":"359","author":"Rosseb\u00f8","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"B67","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1007\/s11883-020-0821-7","article-title":"Calcific aortic valve stenosis and atherosclerotic calcification","volume":"22","author":"S\u00e1","year":"2020","journal-title":"Curr. Atheroscler. Rep."},{"key":"B68","doi-asserted-by":"publisher","first-page":"1171703","DOI":"10.3389\/fcvm.2023.1171703","article-title":"Impact of low-density lipoprotein cholesterol on progression of aortic valve sclerosis and stenosis","volume":"10","author":"Seo","year":"2023","journal-title":"Front. Cardiovasc. Med."},{"key":"B69","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1161\/CIRCIMAGING.112.983288","article-title":"Sex differences in aortic valve calcification","volume":"6","author":"Shames","year":"2013","journal-title":"Circ. Cardiovasc. Imaging."},{"key":"B70","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1038\/s41587-022-01396-x","article-title":"RNA drugs lower lipoprotein(a) and genetically driven cholesterol","volume":"40","author":"Sheridan","year":"2022","journal-title":"Nat. Biotechnol."},{"key":"B71","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1016\/s0735-1097(96)00563-3","article-title":"Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study","volume":"29","author":"Stewart","year":"1997","journal-title":"J. Am. Coll. Cardiol."},{"key":"B72","doi-asserted-by":"publisher","first-page":"e035605","DOI":"10.1161\/JAHA.123.035605","article-title":"Grading of aortic valve calcification severity and risk stratification in aortic stenosis","volume":"13","author":"Tastet","year":"2024","journal-title":"J. Am. Heart Assoc."},{"key":"B73","doi-asserted-by":"publisher","first-page":"2687","DOI":"10.1016\/j.jacc.2015.09.087","article-title":"Increased aortic valve calcification in familial hypercholesterolemia: prevalence, extent, and associated risk factors","volume":"66","author":"Ten","year":"2015","journal-title":"J. Am. Coll. Cardiol."},{"key":"B74","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1194\/jlr.R051870","article-title":"Lipoprotein (a) in calcific aortic valve disease: from genomics to novel drug target for aortic stenosis","volume":"57","author":"Thanassoulis","year":"2016","journal-title":"J. Lipid. Res."},{"key":"B75","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1177\/0165551507087238","article-title":"Bibliometrics to webometrics","volume":"34","author":"Thelwall","year":"2008","journal-title":"J. Inf. Sci."},{"key":"B76","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/s41591-018-0300-7","article-title":"High-performance medicine: the convergence of human and artificial intelligence","volume":"25","author":"Topol","year":"2019","journal-title":"Nat. Med."},{"key":"B77","doi-asserted-by":"publisher","first-page":"96","DOI":"10.3390\/jcdd10030096","article-title":"Lipoprotein(a): its association with calcific aortic valve stenosis, the emerging RNA-related treatments and the hope for a new era in \u201ctreating\u201d aortic valve calcification","volume":"10","author":"Tsamoulis","year":"2023","journal-title":"J. Cardiovasc. Dev. Dis."},{"key":"B78","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1056\/NEJMoa1905239","article-title":"Lipoprotein(a) reduction in persons with cardiovascular disease","volume":"382","author":"Tsimikas","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"B79","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1016\/j.jacc.2021.01.051","article-title":"Emerging RNA therapeutics to lower blood levels of lp(a): JACC focus seminar 2\/4","volume":"77","author":"Tsimikas","year":"2021","journal-title":"J. Am. Coll. Cardiol."},{"key":"B80","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1016\/S0140-6736(15)61252-1","article-title":"Antisense therapy targeting apolipoprotein(a): a randomised, double-blind, placebo-controlled phase 1 study","volume":"386","author":"Tsimikas","year":"2015","journal-title":"Lancet"},{"key":"B81","doi-asserted-by":"publisher","first-page":"20190688","DOI":"10.1259\/bjr.20190688","article-title":"Aortic valve stenosis-multimodality assessment with PET\/CT and PET\/MRI","volume":"93","author":"Tzolos","year":"2020","journal-title":"Br. J. Radiol."},{"key":"B82","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1161\/ATVBAHA.120.313785","article-title":"(18)F-Sodium Fluoride ((18)F-NaF) for imaging microcalcification activity in the cardiovascular system","volume":"40","author":"Tzolos","year":"2020","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"B83","doi-asserted-by":"publisher","first-page":"353","DOI":"10.2967\/jnumed.121.262304","article-title":"Latest advances in multimodality imaging of aortic stenosis","volume":"63","author":"Tzolos","year":"2022","journal-title":"J. Nucl. Med."},{"key":"B84","doi-asserted-by":"publisher","first-page":"4207","DOI":"10.1093\/eurheartj\/ehab626","article-title":"The \u201cten commandments\u201d for the 2021 ESC\/EACTS Guidelines on valvular heart disease","volume":"42","author":"Vahanian","year":"2021","journal-title":"Eur. Heart J."},{"key":"B95","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1194\/jlr.M036343","article-title":"MCP-1 binds to oxidized LDL and is carried by lipoprotein(a) in human plasma","volume":"54","author":"Wiesner","year":"2013","journal-title":"J. Lipid. Res."},{"key":"B85","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.ijcard.2009.03.108","article-title":"Molecular and cellular mechanisms of aortic stenosis","volume":"135","author":"Yetkin","year":"2009","journal-title":"Int. J. Cardiol."},{"key":"B86","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.carpath.2010.12.001","article-title":"The aortic valve microenvironment and its role in calcific aortic valve disease","volume":"20","author":"Yip","year":"2011","journal-title":"Cardiovasc. Pathol."},{"key":"B87","doi-asserted-by":"publisher","first-page":"2387","DOI":"10.1161\/ATVBAHA.114.302523","article-title":"Calcific aortic valve disease: a consensus summary from the alliance of investigators on calcific aortic valve disease","volume":"34","author":"Yutzey","year":"2014","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"B88","doi-asserted-by":"publisher","first-page":"106583","DOI":"10.1016\/j.vph.2019.106583","article-title":"SNF472, a novel anti-crystallization agent, inhibits induced calcification in an in vitro model of human aortic valve calcification","author":"Zabirnyk","year":"2019","journal-title":"Vasc. Pharmacol."},{"key":"B89","doi-asserted-by":"publisher","first-page":"568764","DOI":"10.3389\/fphar.2020.568764","article-title":"A novel ex vivo model of aortic valve calcification. A preliminary report","volume":"11","author":"Zabirnyk","year":"2020","journal-title":"Front. Pharmacol."},{"key":"B90","doi-asserted-by":"publisher","first-page":"734175","DOI":"10.3389\/fcvm.2021.734175","article-title":"Calcific aortic stenosis-A review on acquired mechanisms of the disease and treatments","volume":"8","author":"Zebhi","year":"2021","journal-title":"Front. Cardiovasc. Med."},{"key":"B91","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.7150\/thno.49771","article-title":"ERK1\/2 inhibition reduces vascular calcification by activating miR-126-3p-DKK1\/LRP6 pathway","volume":"11","author":"Zeng","year":"2021","journal-title":"Theranostics"},{"key":"B92","doi-asserted-by":"publisher","first-page":"eadg0478","DOI":"10.1126\/sciadv.adg0478","article-title":"Activation of Piezo1 promotes osteogenic differentiation of aortic valve interstitial cell through YAP-dependent glutaminolysis","volume":"9","author":"Zhong","year":"2023","journal-title":"Sci. Adv."},{"key":"B93","doi-asserted-by":"publisher","first-page":"20366","DOI":"10.1002\/jcp.28638","article-title":"The methylation of Notch1 promoter mediates the osteogenesis differentiation in human aortic valve interstitial cells through Wnt\/\u03b2-catenin signaling","volume":"234","author":"Zhou","year":"2019","journal-title":"J. Cell. Physiol."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1431311\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T07:06:02Z","timestamp":1741849562000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1431311\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,13]]},"references-count":97,"alternative-id":["10.3389\/fphar.2025.1431311"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2025.1431311","relation":{},"ISSN":["1663-9812"],"issn-type":[{"type":"electronic","value":"1663-9812"}],"subject":[],"published":{"date-parts":[[2025,3,13]]},"article-number":"1431311"}}